Bi-specific autoantigen-T cell engagers as targeted immunotherapy for autoreactive B cell depletion in autoimmune diseases.

Publication Year: 2024

DOI:
10.3389/fimmu.2024.1335998

PMCID:
PMC10926275

PMID:
38469301

Journal Information

Full Title: Front Immunol

Abbreviation: Front Immunol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest FS, PI-P and KT were employed by genOway. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision."

Evidence found in paper:

"The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work has been partially supported by Fondazione Regionale per la Ricerca Biomedica (Regione Lombardia), project ID 1737173."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025